Apixaban generic availability 2026?

Short answer: There isn’t a guaranteed US generic apixaban (Eliquis) available by 2026. As of 2024 there was no US‑launch of a generic, and whether one appears in 2026 depends on patent status, settlements, and regulatory approvals. The exact timing has been uncertain and can change with litigation and patent rulings.

How to check up-to-date status (country‑specific):
- United States: FDA Orange Book (search for apixaban or Eliquis) to see current patent, exclusivity, and any approved generics.
- Patent details: USPTO Patent Center or patent‑watch sources to see expiry dates and any ongoing disputes.
- Company announcements: Pfizer and Bristol Myers Squibb press releases may announce settlements or generic launches.
- If you’re outside the US: check your national regulatory authority (e.g., EMA in Europe, Health Canada) for generic approvals and market availability.

If you’re considering alternatives or cost options now:
- Talk with your prescriber about alternatives (other DOACs) and whether a generic option might be appropriate in your location.
- Ask the pharmacist about generic availability and price, and about patient assistance programs.

If you tell me your country, I can outline the exact steps and sources most relevant for that region.